27.11.2020
Since November 2020, the NMI is a partner in the international ZIM network "4D Bioprinting" (FKZ 16KN098801). This network consists of European SMEs and research institutions that are jointly researching innovative bio inks and ...
[read more]
18.11.2020
Kathrin Stadelmann, scientist of the Biomedical Micro and Nano Engineering group at the NMI, won the second prize at the Young Scientists Lecture.
3.7.2020
A nationwide antibody study by the Helmholtz Centre for Infection Research (HZI) was launched in the district of Reutlingen at the beginning of July with the aim of gaining a better overview of the occurrence of SARS-CoV-2 infections.
25.6.2020
While the Innovation Alliance Baden-Württemberg, in short innBW, can already look back on a long history, the 13 member institutes joined together to form an association on 24 June.
10.6.2020
The NMI is collaborating in an international project consortium named CORESMA in which clinical, epidemiological and immunological data will be collected and triangulated to assist healthcare systems in their effort to make evidence-based decisions regarding the corona Crisis.
13.5.2020
The NMI Reutlingen is currently tackling a major problem associated with antibody tests for the detection of COVID-19: false positive test results.
6.5.2020
NMI supports the University Hospital of Tübingen in clarifying the material question.
25.3.2020
The NMI Natural and Medical Sciences Institute at the University of Tübingen is focusing its research efforts into infections with the novel coronavirus (SARS-CoV-2).
23.3.2020
Together with Proteona and Synovo, the NMI will use its platform for patient-derived microtumours for drug screening and the discovery of potential drug candidates.
19.3.2020
In order to protect individuals as well as society as a whole, the NMI has also taken measures to protect employees in the light of the corona pandemic.
10.3.2020
In cooperation with the medical technology company Joline, in the future the NMI will conduct research on central venous catheters that have an antibacterial effect due to their water-loving surface. A positive side effect: the researchers expect that the new surface will also significantly reduce the risk of thrombosis.
25.2.2020
After the NMI and the Karlsruhe Institute of Technology (KIT) have already worked on joint projects in the past, a long-term cooperation will now be sealed by a cooperation agreement.
18.2.2020
Last week, the NMI, represented by Prof. Katja Schenke-Layland, Dr. Stefan Raible, Dr. Hanna Hartmann and Dr.-Ing René von Metzen, travelled to Nancy, France, to participate in the German-French Forum.
21.1.2020
After Prof. Katja Schenke-Layland had already attended the "forum gesundheitsstandort BW" in October 2019 as spokesperson for the subject area of business-oriented research, innovations and value creation in the healthcare industry, she travelled to Brussels together with Winfried Kretschmann on 21 January 2020.
Innovative strength and NMI - these are two terms that complement each other perfectly, not only in our opinion. For that reason, the Chamber of Industry and Commerce Reutlingen invited Katja Schenke-Layland to a panel discussion ...
27.11.2019
Nicole Schneiderhan-Marra will be representing the NMI with a talk.
26.11.2019
Scientists from the NMI Natural and Medical Sciences Institute at the University of Tübingen, a private research foundation dedicated to applied and translational research, and of contract research provider NMI TT Pharmaservices, announced two publication.
19.11.2019
Thomas Joos will be representing the NMI at Barcelona.
7.11.2019
Ellena Hönig will be representing the NMI with a talk.
Organs-on-a-chip, organoids & other microphysiological systems as advanced human in vitro models
5.11.2019
3.10.2019
Thomas Joos will be representing the NMI in London.
1.9.2019
The NMI electron microscopy is strongly represented at the Conference
21.8.2019
An international consortium achieved further advancement in understanding the disease pathology of schizophrenia, as published in „Translational Psychiatry“
6.8.2019
LI-COR Biosciences Introduces DigiWest to Accelerate Targeted Therapeutics Development
23.7.2019
Engineering in Medicine and Biology
Meng-Jung Lee (Neurophysics Group) presents sinusoidal electrical stimulation
12.7.2019
Hansjürgen Volkmer at the FENS in Belgrad.
2.7.2019
27.6.2019
Tools, die wesentliche Services und Funktionen ermöglichen, einschließlich Identitätsprüfung, Servicekontinuität und Standortsicherheit. Diese Option kann nicht abgelehnt werden.
Tools, die anonyme Daten über Website-Nutzung und -Funktionalität sammeln. Wir nutzen die Erkenntnisse, um unsere Produkte, Dienstleistungen und das Benutzererlebnis zu verbessern.
Integration von Social Media Plugins.
